L'Oréal CEO Says GLP-1 Weight-Loss Drugs Are Reshaping Skincare Demand
The growing popularity of GLP-1 weight-loss medicines is influencing beauty and skincare consumption, prompting L'Oréal to explore products addressing skin changes associated with rapid weight loss. L'Oréal CEO Nicolas Hieronimus highlighted the trend during an investor call on Thursday following the company's financial results for the quarter ended Sept 30. He described the increasing use of…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
